Market Reports

How Much Growth Is Anticipated In The Checkpoint Inhibitors Market Size From 2026 To 2035? The checkpoint inhibitors market size has grown strongly in recent years. It will grow from $46.27 billion in 2025 to $49.12 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to limited availability of checkpoint inhibitors, reliance on conventional chemotherapy and radiotherapy, increasing incidence of cancers, rising awareness of immunotherapy options, regulatory approvals for first-generation inhibitors. The checkpoint inhibitors market size is expected to see strong growth in the next few years. It will grow to $63.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to launch of novel pd-1, pd-l1, and ctla-4 inhibitors, expansion of car t-cell therapies, growth in combination therapy research, increasing adoption of personalized cancer treatments, rising invest...